Moxifloxacin Stulln

Moxifloxacin, the active ingredient in Moxifloxacin Stulln, is a fluoroquinolone antibiotic presented as a topical ophthalmic solution for ocular use. It treats bacterial conjunctivitis, keratitis and other ocular bacterial infections in patients requiring antibiotic therapy.

GNH USA supplies Moxifloxacin Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibiotic used to manage bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Keratitis: eradicates causative bacteria, helping to preserve corneal integrity and visual acuity. - Other ocular bacterial infections: provides broad‑spectrum coverage for Gram‑positive and Gram‑negative pathogens affecting the ocular surface.

Moxifloxacin ophthalmic solution may cause local and systemic reactions, although many patients tolerate it well.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Temporary blurred vision. - Tearing or increased lacrimation. - Mild headache. - Dry eye sensation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling, rash or difficulty breathing. - Corneal ulceration or perforation. - Persistent or worsening eye pain. - Vision loss. - Tendon rupture (systemic exposure). - Central nervous system effects such as seizures (rare).

Before using Moxifloxacin ophthalmic solution, consider the following safety measures.

- Allergy assessment: avoid if known hypersensitivity to fluoroquinolones. - Contact lens use: remove lenses before instillation and wait before reinserting. - Pregnancy and lactation: consult a healthcare professional; safety data are limited. - Concomitant ocular disease: use with caution in patients with corneal epithelial defects. - Systemic fluoroquinolone exposure: monitor for tendon or CNS adverse events. - Store below 25°C: keep in the original container, protect from light and moisture.

Moxifloxacin ophthalmic solution can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon rupture. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may heighten risk of corneal complications.

Moderate Interactions (Monitor Closely): - Antacids or supplements containing aluminum, magnesium, calcium, or iron: can reduce systemic absorption if taken orally. - Corticosteroid eye drops: may mask signs of infection. - Warfarin: potential for enhanced anticoagulant effect with systemic exposure.